Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
4.873
Zitationen
4
Autoren
1983
Jahr
Abstract
Four persons developed marked parkinsonism after using an illicit drug intravenously. Analysis of the substance injected by two of these patients revealed primarily 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) with trace amounts of 1-methyl-4-phenyl-4-propionoxy-piperidine (MPPP). On the basis of the striking parkinsonian features observed in our patients, and additional pathological data from one previously reported case, it is proposed that this chemical selectively damages cells in the substantia nigra.
Ähnliche Arbeiten
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 · 5.859 Zit.
ILAE Official Report: A practical clinical definition of epilepsy
2014 · 5.719 Zit.
Proposal for Revised Classification of Epilepsies and Epileptic Syndromes
1989 · 5.352 Zit.
Early Identification of Refractory Epilepsy
2000 · 5.073 Zit.
<scp>ILAE</scp> classification of the epilepsies: Position paper of the <scp>ILAE</scp> Commission for Classification and Terminology
2017 · 4.735 Zit.